UPDATED Jul 22, 2022
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
4119SCI Pharmtech | NT$79.50 | 1.4% | 5.4% | NT$7.6b | NT$84.00 | PE137.4x | E84.8% | 0% | ||
6576Foresee Pharmaceuticals | NT$113.50 | 3.2% | 28.1% | NT$13.4b | NT$130.33 | PS60.6x | E101.0% | n/a | ||
1777SYN-TECH Chem. & Pharm | NT$65.20 | -0.5% | -13.5% | NT$2.6b | NT$80.00 | PE30.3x | E48.1% | 3.0% | ||
1762Chunghwa Chemical Synthesis & Biotech | NT$55.90 | 3.9% | -9.3% | NT$4.3b | NT$84.63 | PE10.1x | E8.7% | 2.3% | ||
6492Senhwa Biosciences | NT$64.80 | 4.5% | -53.2% | NT$5.7b | NT$84.00 | PS8840.4x | E74.0% | n/a | ||
4147TaiMed Biologics | NT$57.60 | 2.3% | -8.1% | NT$14.5b | NT$101.33 | PS40.1x | E139.7% | n/a |